We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Nvidia topping Apple as the most valuable company in the world and joining the Dow Jones Industrial Average. Why Novo Nordisk and Eli Lilly are giving totally different reads on the markets for GLP-1 ...

Although internships aren't required for Lilly & Meghen Hengerer's masters programs, they view it as an opportunity to get ready for once their athletic careers are over.

Asian shares mostly declined Thursday as investors grappled with uncertainty ahead of the United States presidential election ...

U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company. The S&P 500 slipped 0.3% after drifting between small gains and ...

Tech megacaps are in the spotlight after Alphabet's quarterly results showed its high-spending push into AI is starting to ...

Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales more than doubled year over year to $3.1 billion. Sales for Zepbound, which ...

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. The drugmaker on ...

Google just posted its latest earnings report, and it turned a pretty healthy profit. While the company has been making a ...

A mixed set of profit reports from giants like Google’s parent company and Eli Lilly has stock indexes basically churning in ...

On Wednesday, Eli Lilly and Co (NYSE:LLY) stock plummeted after the company released worse-than-expected third-quarter earnings and lowered 2024 guidance. The U.S. pharma giant reported third-quarter ...